BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Rai D, Kim SW, McKeller MR, Dahia PL, Aguiar RC. Targeting of SMAD5 links microRNA-155 to the TGF-beta pathway and lymphomagenesis. Proc Natl Acad Sci USA. 2010;107:3111-3116. [PMID: 20133617 DOI: 10.1073/pnas.0910667107] [Cited by in Crossref: 145] [Cited by in F6Publishing: 148] [Article Influence: 12.1] [Reference Citation Analysis]
Number Citing Articles
1 Gentile G, Morello G, La Cognata V, Guarnaccia M, Conforti FL, Cavallaro S. Dysregulated miRNAs as Biomarkers and Therapeutical Targets in Neurodegenerative Diseases. JPM 2022;12:770. [DOI: 10.3390/jpm12050770] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Ning Y, Zhang L, Wang W, Wu S. Effect of genetic variants in the SMAD1 and SMAD5 genes promoter on growth and beef quality traits in cattle. Gene 2022;819:146220. [PMID: 35093446 DOI: 10.1016/j.gene.2022.146220] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Tanga BM, Fang X, Bang S, Seong G, De Zoysa M, Saadeldin IM, Lee S, Cho J. MiRNA-155 inhibition enhances porcine embryo preimplantation developmental competence by upregulating ZEB2 and downregulating ATF4. Theriogenology 2022;183:90-7. [DOI: 10.1016/j.theriogenology.2022.02.019] [Reference Citation Analysis]
4 Timmins MA, Ringshausen I. Transforming Growth Factor-Beta Orchestrates Tumour and Bystander Cells in B-Cell Non-Hodgkin Lymphoma. Cancers 2022;14:1772. [DOI: 10.3390/cancers14071772] [Reference Citation Analysis]
5 Fernandes M, Marques H, Teixeira AL, Medeiros R. Competitive Endogenous RNA Network Involving miRNA and lncRNA in Non-Hodgkin Lymphoma: Current Advances and Clinical Perspectives. Biomedicines 2021;9:1934. [DOI: 10.3390/biomedicines9121934] [Reference Citation Analysis]
6 Sánchez-Gloria JL, Carbó R, Buelna-Chontal M, Osorio-Alonso H, Henández-Díazcouder A, de la Fuente-León RL, Sandoval J, Sánchez F, Rubio-Gayosso I, Sánchez-Muñoz F. Cold exposure aggravates pulmonary arterial hypertension through increased miR-146a-5p, miR-155-5p and cytokines TNF-α, IL-1β, and IL-6. Life Sci 2021;287:120091. [PMID: 34717910 DOI: 10.1016/j.lfs.2021.120091] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
7 Gokavi J, Sadawarte S, Shelke A, Kulkarni-Kale U, Thakar M, Saxena V. Inhibition of miR-155 Promotes TGF-β Mediated Suppression of HIV Release in the Cervical Epithelial Cells. Viruses 2021;13:2266. [PMID: 34835072 DOI: 10.3390/v13112266] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
8 Mahdloo T, Sahami P, Ramezani R, Jafarinia M, Goudarzi H, Babashah S. Up-regulation of miR-155 potentiates CD34+ CML stem/progenitor cells to escape from the growth-inhibitory effects of TGF-ß1 and BMP signaling. EXCLI J 2021;20:748-63. [PMID: 33907541 DOI: 10.17179/excli2021-3404] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
9 Chen M, Wang F, Xia H, Yao S. MicroRNA-155: Regulation of Immune Cells in Sepsis. Mediators Inflamm 2021;2021:8874854. [PMID: 33505221 DOI: 10.1155/2021/8874854] [Cited by in Crossref: 1] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
10 Sasi B, Ethiraj P, Myers J, Lin AP, Jiang S, Qiu Z, Holder KN, Aguiar RCT. Regulation of PD-L1 expression is a novel facet of cyclic-AMP-mediated immunosuppression. Leukemia 2021;35:1990-2001. [PMID: 33299141 DOI: 10.1038/s41375-020-01105-0] [Cited by in F6Publishing: 8] [Reference Citation Analysis]
11 Drees EEE, Pegtel DM. Circulating miRNAs as Biomarkers in Aggressive B Cell Lymphomas. Trends Cancer 2020;6:910-23. [PMID: 32660885 DOI: 10.1016/j.trecan.2020.06.003] [Cited by in Crossref: 5] [Cited by in F6Publishing: 8] [Article Influence: 2.5] [Reference Citation Analysis]
12 Sun C, Zhang H, Wang X, Liu X. Ligamentum flavum fibrosis and hypertrophy: Molecular pathways, cellular mechanisms, and future directions. FASEB J 2020;34:9854-68. [PMID: 32608536 DOI: 10.1096/fj.202000635R] [Cited by in Crossref: 6] [Cited by in F6Publishing: 17] [Article Influence: 3.0] [Reference Citation Analysis]
13 Gluud M, Willerslev-Olsen A, Gjerdrum LMR, Lindahl LM, Buus TB, Andersen MH, Bonefeld CM, Krejsgaard T, Litvinov IV, Iversen L, Becker JC, Persson JL, Koralov SB, Litman T, Geisler C, Woetmann A, Odum N. MicroRNAs in the Pathogenesis, Diagnosis, Prognosis and Targeted Treatment of Cutaneous T-Cell Lymphomas. Cancers (Basel) 2020;12:E1229. [PMID: 32414221 DOI: 10.3390/cancers12051229] [Cited by in Crossref: 5] [Cited by in F6Publishing: 11] [Article Influence: 2.5] [Reference Citation Analysis]
14 Ni C, Fang QQ, Chen WZ, Jiang JX, Jiang Z, Ye J, Zhang T, Yang L, Meng FB, Xia WJ, Zhong M, Huang J. Breast cancer-derived exosomes transmit lncRNA SNHG16 to induce CD73+γδ1 Treg cells. Signal Transduct Target Ther 2020;5:41. [PMID: 32345959 DOI: 10.1038/s41392-020-0129-7] [Cited by in Crossref: 35] [Cited by in F6Publishing: 87] [Article Influence: 17.5] [Reference Citation Analysis]
15 Busch C, Wheadon H. Bone marrow niche crosses paths with BMPs: a road to protection and persistence in CML. Biochem Soc Trans 2019;47:1307-25. [PMID: 31551354 DOI: 10.1042/BST20190221] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
16 Dong X, Mu L, Liu X, Zhu H, Yang S, Lai X, Liu H, Feng H, Lu Q, Zhou BS, Chen H, Chen G, Lovell JF, Hong D, Fang C. Biomimetic, Hypoxia‐Responsive Nanoparticles Overcome Residual Chemoresistant Leukemic Cells with Co‐Targeting of Therapy‐Induced Bone Marrow Niches. Adv Funct Mater 2020;30:2000309. [DOI: 10.1002/adfm.202000309] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 8.5] [Reference Citation Analysis]
17 Cummins EP, Strowitzki MJ, Taylor CT. Mechanisms and Consequences of Oxygen and Carbon Dioxide Sensing in Mammals. Physiol Rev 2020;100:463-88. [PMID: 31539306 DOI: 10.1152/physrev.00003.2019] [Cited by in Crossref: 26] [Cited by in F6Publishing: 41] [Article Influence: 8.7] [Reference Citation Analysis]
18 Jin Y, Li JL. Olfactomedin-like 3: possible functions in embryonic development and tumorigenesis. Chin Med J (Engl) 2019;132:1733-8. [PMID: 31261202 DOI: 10.1097/CM9.0000000000000309] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
19 Piket E, Zheleznyakova GY, Kular L, Jagodic M. Small non-coding RNAs as important players, biomarkers and therapeutic targets in multiple sclerosis: A comprehensive overview. J Autoimmun 2019;101:17-25. [PMID: 31014917 DOI: 10.1016/j.jaut.2019.04.002] [Cited by in Crossref: 25] [Cited by in F6Publishing: 33] [Article Influence: 8.3] [Reference Citation Analysis]
20 Tang L, Peng YZ, Li CG, Jiang HW, Mei H, Hu Y. Prognostic and Clinicopathological Significance of MiR-155 in Hematologic Malignancies: A Systematic Review and Meta-analysis. J Cancer 2019;10:654-64. [PMID: 30719163 DOI: 10.7150/jca.28537] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
21 Tao Y, Ai R, Hao Y, Jiang L, Dan H, Ji N, Zeng X, Zhou Y, Chen Q. Role of miR-155 in immune regulation and its relevance in oral lichen planus. Exp Ther Med 2019;17:575-86. [PMID: 30651838 DOI: 10.3892/etm.2018.7019] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
22 Sun W, Zhang L, Lin L, Wang W, Ge Y, Liu Y, Yang B, Hou J, Cheng X, Chen X, Wang Z. Chronic psychological stress impairs germinal center response by repressing miR-155. Brain Behav Immun 2019;76:48-60. [PMID: 30414952 DOI: 10.1016/j.bbi.2018.11.002] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
23 Di Marco M, Ramassone A, Pagotto S, Anastasiadou E, Veronese A, Visone R. MicroRNAs in Autoimmunity and Hematological Malignancies. Int J Mol Sci 2018;19:E3139. [PMID: 30322050 DOI: 10.3390/ijms19103139] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 3.8] [Reference Citation Analysis]
24 Xi W, Zhao X, Wu M, Jia W, Li H. Lack of microRNA-155 ameliorates renal fibrosis by targeting PDE3A/TGF-β1/Smad signaling in mice with obstructive nephropathy. Cell Biol Int 2018;42:1523-32. [PMID: 30080287 DOI: 10.1002/cbin.11038] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
25 Velapasamy S, Dawson CW, Young LS, Paterson IC, Yap LF. The Dynamic Roles of TGF-β Signalling in EBV-Associated Cancers. Cancers (Basel) 2018;10:E247. [PMID: 30060514 DOI: 10.3390/cancers10080247] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 2.8] [Reference Citation Analysis]
26 Abtin M, Alivand MR, Khaniani MS, Bastami M, Zaeifizadeh M, Derakhshan SM. Simultaneous downregulation of miR-21 and miR-155 through oleuropein for breast cancer prevention and therapy. J Cell Biochem. 2018;119:7151-7165. [PMID: 29905007 DOI: 10.1002/jcb.26754] [Cited by in Crossref: 19] [Cited by in F6Publishing: 24] [Article Influence: 4.8] [Reference Citation Analysis]
27 Szablewski V, Bret C, Kassambara A, Devin J, Cartron G, Costes-Martineau V, Moreaux J. An epigenetic regulator-related score (EpiScore) predicts survival in patients with diffuse large B cell lymphoma and identifies patients who may benefit from epigenetic therapy. Oncotarget 2018;9:19079-99. [PMID: 29721185 DOI: 10.18632/oncotarget.24901] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
28 Stelling A, Hashwah H, Bertram K, Manz MG, Tzankov A, Müller A. The tumor suppressive TGF-β/SMAD1/S1PR2 signaling axis is recurrently inactivated in diffuse large B-cell lymphoma. Blood 2018;131:2235-46. [PMID: 29615404 DOI: 10.1182/blood-2017-10-810630] [Cited by in Crossref: 21] [Cited by in F6Publishing: 30] [Article Influence: 5.3] [Reference Citation Analysis]
29 Wang B, Fu M, Liu Y, Wang Y, Li X, Cao H, Zheng SJ. gga-miR-155 Enhances Type I Interferon Expression and Suppresses Infectious Burse Disease Virus Replication via Targeting SOCS1 and TANK. Front Cell Infect Microbiol 2018;8:55. [PMID: 29564226 DOI: 10.3389/fcimb.2018.00055] [Cited by in Crossref: 25] [Cited by in F6Publishing: 32] [Article Influence: 6.3] [Reference Citation Analysis]
30 Zhou X, Mao Y, Zhu J, Meng F, Chen Q, Tao L, Li R, Fu F, Liu C, Hu Y, Wang W, Zhang H, Hua D, Chen W, Zhang X. TGF-β1 promotes colorectal cancer immune escape by elevating B7-H3 and B7-H4 via the miR-155/miR-143 axis. Oncotarget 2016;7:67196-211. [PMID: 27626488 DOI: 10.18632/oncotarget.11950] [Cited by in Crossref: 41] [Cited by in F6Publishing: 48] [Article Influence: 10.3] [Reference Citation Analysis]
31 Su Y, Sun B, Lin X, Zhao X, Ji W, He M, Qian H, Song X, Yang J, Wang J, Chen J. Therapeutic strategy with artificially-designed i-lncRNA targeting multiple oncogenic microRNAs exhibits effective antitumor activity in diffuse large B-cell lymphoma. Oncotarget 2016;7:49143-55. [PMID: 27172795 DOI: 10.18632/oncotarget.9237] [Cited by in Crossref: 12] [Cited by in F6Publishing: 15] [Article Influence: 3.0] [Reference Citation Analysis]
32 Bach DH, Park HJ, Lee SK. The Dual Role of Bone Morphogenetic Proteins in Cancer. Mol Ther Oncolytics 2018;8:1-13. [PMID: 29234727 DOI: 10.1016/j.omto.2017.10.002] [Cited by in Crossref: 73] [Cited by in F6Publishing: 83] [Article Influence: 14.6] [Reference Citation Analysis]
33 Solé C, Larrea E, Di Pinto G, Tellaetxe M, Lawrie CH. miRNAs in B-cell lymphoma: Molecular mechanisms and biomarker potential. Cancer Letters 2017;405:79-89. [DOI: 10.1016/j.canlet.2017.07.020] [Cited by in Crossref: 14] [Cited by in F6Publishing: 21] [Article Influence: 2.8] [Reference Citation Analysis]
34 Zhuang G, Sun A, Teng M, Luo J. A Tiny RNA that Packs a Big Punch: The Critical Role of a Viral miR-155 Ortholog in Lymphomagenesis in Marek's Disease. Front Microbiol 2017;8:1169. [PMID: 28694799 DOI: 10.3389/fmicb.2017.01169] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 3.0] [Reference Citation Analysis]
35 Sinha PB, Tesfaye D, Rings F, Hossien M, Hoelker M, Held E, Neuhoff C, Tholen E, Schellander K, Salilew-Wondim D. MicroRNA-130b is involved in bovine granulosa and cumulus cells function, oocyte maturation and blastocyst formation. J Ovarian Res 2017;10:37. [PMID: 28629378 DOI: 10.1186/s13048-017-0336-1] [Cited by in Crossref: 22] [Cited by in F6Publishing: 31] [Article Influence: 4.4] [Reference Citation Analysis]
36 Kumar Kingsley SM, Vishnu Bhat B. Role of MicroRNAs in the development and function of innate immune cells. International Reviews of Immunology 2017;36:154-75. [DOI: 10.1080/08830185.2017.1284212] [Cited by in Crossref: 18] [Cited by in F6Publishing: 22] [Article Influence: 3.6] [Reference Citation Analysis]
37 Gu Y, Ma L, Song L, Li X, Chen D, Bai X. miR-155 Inhibits Mouse Osteoblast Differentiation by Suppressing SMAD5 Expression. Biomed Res Int 2017;2017:1893520. [PMID: 28473977 DOI: 10.1155/2017/1893520] [Cited by in Crossref: 17] [Cited by in F6Publishing: 23] [Article Influence: 3.4] [Reference Citation Analysis]
38 Zhu FQ, Zeng L, Tang N, Tang YP, Zhou BP, Li FF, Wu WG, Zeng XB, Peng SS. MicroRNA-155 Downregulation Promotes Cell Cycle Arrest and Apoptosis in Diffuse Large B-Cell Lymphoma. Oncol Res 2016;24:415-27. [PMID: 28281962 DOI: 10.3727/096504016X14685034103473] [Cited by in Crossref: 24] [Cited by in F6Publishing: 29] [Article Influence: 4.8] [Reference Citation Analysis]
39 Bedewy AML, Elmaghraby SM, Shehata AA, Kandil NS. Prognostic Value of miRNA-155 Expression in B-Cell Non-Hodgkin Lymphoma. Turk J Haematol 2017;34:207-12. [PMID: 28148469 DOI: 10.4274/tjh.2016.0286] [Cited by in Crossref: 2] [Cited by in F6Publishing: 12] [Article Influence: 0.4] [Reference Citation Analysis]
40 Pon JR, Marra MA. MEF2 transcription factors: developmental regulators and emerging cancer genes. Oncotarget 2016;7:2297-312. [PMID: 26506234 DOI: 10.18632/oncotarget.6223] [Cited by in Crossref: 75] [Cited by in F6Publishing: 76] [Article Influence: 12.5] [Reference Citation Analysis]
41 Matsukura S, Osakabe Y, Sekiguchi A, Inoue D, Kakiuchi Y, Funaki T, Yamazaki Y, Takayasu H, Tateno H, Kato E, Wakabayashi A, Hayashi M, Ishii G, Yamaguchi F, Tsuchiya Y, Kasahara K, Sagara H, Kokubu F. Overexpression of microRNA-155 suppresses chemokine expression induced by Interleukin-13 in BEAS-2B human bronchial epithelial cells. Allergol Int 2016;65 Suppl:S17-23. [PMID: 27497617 DOI: 10.1016/j.alit.2016.04.018] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 2.5] [Reference Citation Analysis]
42 Hata A, Chen YG. TGF-β Signaling from Receptors to Smads. Cold Spring Harb Perspect Biol 2016;8:a022061. [PMID: 27449815 DOI: 10.1101/cshperspect.a022061] [Cited by in Crossref: 255] [Cited by in F6Publishing: 337] [Article Influence: 42.5] [Reference Citation Analysis]
43 Liu N, Wang L, Sun C, Yang L, Sun W, Peng Q. MicroRNA-125b-5p suppresses Brucella abortus intracellular survival via control of A20 expression. BMC Microbiol 2016;16:171. [PMID: 27473222 DOI: 10.1186/s12866-016-0788-2] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 3.0] [Reference Citation Analysis]
44 Szűcs D, Béres NJ, Rokonay R, Boros K, Borka K, Kiss Z, Arató A, Szabó AJ, Vannay &, Sziksz E, Bereczki C, Veres G. Increased duodenal expression of miR-146a and -155 in pediatric Crohn’s disease. World J Gastroenterol 2016; 22(26): 6027-6035 [PMID: 27468194 DOI: 10.3748/wjg.v22.i26.6027] [Cited by in CrossRef: 17] [Cited by in F6Publishing: 16] [Article Influence: 2.8] [Reference Citation Analysis]
45 Lowery JW, Brookshire B, Rosen V. A Survey of Strategies to Modulate the Bone Morphogenetic Protein Signaling Pathway: Current and Future Perspectives. Stem Cells Int 2016;2016:7290686. [PMID: 27433166 DOI: 10.1155/2016/7290686] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 2.3] [Reference Citation Analysis]
46 Xue Q, Yu C, Wang Y, Liu L, Zhang K, Fang C, Liu F, Bian G, Song B, Yang A, Ju G, Wang J. miR-9 and miR-124 synergistically affect regulation of dendritic branching via the AKT/GSK3β pathway by targeting Rap2a. Sci Rep 2016;6:26781. [PMID: 27221778 DOI: 10.1038/srep26781] [Cited by in Crossref: 36] [Cited by in F6Publishing: 44] [Article Influence: 6.0] [Reference Citation Analysis]
47 Due H, Svendsen P, Bødker JS, Schmitz A, Bøgsted M, Johnsen HE, El-Galaly TC, Roug AS, Dybkær K. miR-155 as a Biomarker in B-Cell Malignancies. Biomed Res Int 2016;2016:9513037. [PMID: 27294145 DOI: 10.1155/2016/9513037] [Cited by in Crossref: 27] [Cited by in F6Publishing: 32] [Article Influence: 4.5] [Reference Citation Analysis]
48 Go H, Jang JY, Kim PJ, Kim YG, Nam SJ, Paik JH, Kim TM, Heo DS, Kim CW, Jeon YK. MicroRNA-21 plays an oncogenic role by targeting FOXO1 and activating the PI3K/AKT pathway in diffuse large B-cell lymphoma. Oncotarget 2015;6:15035-49. [PMID: 25909227 DOI: 10.18632/oncotarget.3729] [Cited by in Crossref: 62] [Cited by in F6Publishing: 75] [Article Influence: 10.3] [Reference Citation Analysis]
49 Fernandez-Mercado M, Manterola L, Lawrie CH. MicroRNAs in Lymphoma: Regulatory Role and Biomarker Potential. Curr Genomics 2015;16:349-58. [PMID: 27047255 DOI: 10.2174/1389202916666150707160147] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 2.3] [Reference Citation Analysis]
50 Delić D, Eisele C, Schmid R, Baum P, Wiech F, Gerl M, Zimdahl H, Pullen SS, Urquhart R. Urinary Exosomal miRNA Signature in Type II Diabetic Nephropathy Patients. PLoS One 2016;11:e0150154. [PMID: 26930277 DOI: 10.1371/journal.pone.0150154] [Cited by in Crossref: 102] [Cited by in F6Publishing: 117] [Article Influence: 17.0] [Reference Citation Analysis]
51 Osaka E, Kelly AD, Spentzos D, Choy E, Yang X, Shen JK, Yang P, Mankin HJ, Hornicek FJ, Duan Z. MicroRNA-155 expression is independently predictive of outcome in chordoma. Oncotarget 2015;6:9125-39. [PMID: 25823817 DOI: 10.18632/oncotarget.3273] [Cited by in Crossref: 25] [Cited by in F6Publishing: 25] [Article Influence: 4.2] [Reference Citation Analysis]
52 Ni H, Tong R, Zou L, Song G, Cho WC. MicroRNAs in diffuse large B-cell lymphoma. Oncol Lett 2016;11:1271-80. [PMID: 26893730 DOI: 10.3892/ol.2015.4064] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 1.7] [Reference Citation Analysis]
53 Caballero-Garrido E, Pena-Philippides JC, Lordkipanidze T, Bragin D, Yang Y, Erhardt EB, Roitbak T. In Vivo Inhibition of miR-155 Promotes Recovery after Experimental Mouse Stroke. J Neurosci 2015;35:12446-64. [PMID: 26354913 DOI: 10.1523/JNEUROSCI.1641-15.2015] [Cited by in Crossref: 109] [Cited by in F6Publishing: 112] [Article Influence: 15.6] [Reference Citation Analysis]
54 Camicia R, Winkler HC, Hassa PO. Novel drug targets for personalized precision medicine in relapsed/refractory diffuse large B-cell lymphoma: a comprehensive review. Mol Cancer 2015;14:207. [PMID: 26654227 DOI: 10.1186/s12943-015-0474-2] [Cited by in Crossref: 88] [Cited by in F6Publishing: 100] [Article Influence: 12.6] [Reference Citation Analysis]
55 Jing W, Zhang X, Sun W, Hou X, Yao Z, Zhu Y. CRISPR/CAS9-Mediated Genome Editing of miRNA-155 Inhibits Proinflammatory Cytokine Production by RAW264.7 Cells. Biomed Res Int 2015;2015:326042. [PMID: 26697483 DOI: 10.1155/2015/326042] [Cited by in Crossref: 28] [Cited by in F6Publishing: 35] [Article Influence: 4.0] [Reference Citation Analysis]
56 Zhang Y, Wei Z, Li J, Liu P. Molecular pathogenesis of lymphomas of mucosa-associated lymphoid tissue--from (auto)antigen driven selection to the activation of NF-κB signaling. Sci China Life Sci. 2015;58:1246-1255. [PMID: 26612043 DOI: 10.1007/s11427-015-4977-2] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
57 Guo L, Zhang Y, Zhang L, Huang F, Li J, Wang S. MicroRNAs, TGF-β signaling, and the inflammatory microenvironment in cancer. Tumour Biol 2016;37:115-25. [PMID: 26563372 DOI: 10.1007/s13277-015-4374-2] [Cited by in Crossref: 58] [Cited by in F6Publishing: 63] [Article Influence: 8.3] [Reference Citation Analysis]
58 Koues OI, Oltz EM, Payton JE. Short-Circuiting Gene Regulatory Networks: Origins of B Cell Lymphoma. Trends Genet 2015;31:720-31. [PMID: 26604030 DOI: 10.1016/j.tig.2015.09.006] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
59 Ranganath P. MicroRNA-155 and Its Role in Malignant Hematopoiesis. Biomark Insights 2015;10:95-102. [PMID: 26523117 DOI: 10.4137/BMI.S27676] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 1.9] [Reference Citation Analysis]
60 Kim JD, Lee A, Choi J, Park Y, Kang H, Chang W, Lee MS, Kim J. Epigenetic modulation as a therapeutic approach for pulmonary arterial hypertension. Exp Mol Med 2015;47:e175. [PMID: 26228095 DOI: 10.1038/emm.2015.45] [Cited by in Crossref: 33] [Cited by in F6Publishing: 34] [Article Influence: 4.7] [Reference Citation Analysis]
61 Lin AP, Abbas S, Kim SW, Ortega M, Bouamar H, Escobedo Y, Varadarajan P, Qin Y, Sudderth J, Schulz E, Deutsch A, Mohan S, Ulz P, Neumeister P, Rakheja D, Gao X, Hinck A, Weintraub ST, DeBerardinis RJ, Sill H, Dahia PL, Aguiar RC. D2HGDH regulates alpha-ketoglutarate levels and dioxygenase function by modulating IDH2. Nat Commun 2015;6:7768. [PMID: 26178471 DOI: 10.1038/ncomms8768] [Cited by in Crossref: 36] [Cited by in F6Publishing: 43] [Article Influence: 5.1] [Reference Citation Analysis]
62 Pathak S, Grillo AR, Scarpa M, Brun P, D’Incà R, Nai L, Banerjee A, Cavallo D, Barzon L, Palù G. MiR-155 modulates the inflammatory phenotype of intestinal myofibroblasts by targeting SOCS1 in ulcerative colitis. Exp Mol Med. 2015;47:e164. [PMID: 25998827 DOI: 10.1038/emm.2015.21] [Cited by in Crossref: 47] [Cited by in F6Publishing: 58] [Article Influence: 6.7] [Reference Citation Analysis]
63 Mashima R. Physiological roles of miR-155. Immunology 2015;145:323-33. [PMID: 25829072 DOI: 10.1111/imm.12468] [Cited by in Crossref: 86] [Cited by in F6Publishing: 101] [Article Influence: 12.3] [Reference Citation Analysis]
64 Shih HY, Sciumè G, Poholek AC, Vahedi G, Hirahara K, Villarino AV, Bonelli M, Bosselut R, Kanno Y, Muljo SA, O'Shea JJ. Transcriptional and epigenetic networks of helper T and innate lymphoid cells. Immunol Rev 2014;261:23-49. [PMID: 25123275 DOI: 10.1111/imr.12208] [Cited by in Crossref: 64] [Cited by in F6Publishing: 62] [Article Influence: 9.1] [Reference Citation Analysis]
65 Pan H, Jiang Y, Boi M, Tabbò F, Redmond D, Nie K, Ladetto M, Chiappella A, Cerchietti L, Shaknovich R, Melnick AM, Inghirami GG, Tam W, Elemento O. Epigenomic evolution in diffuse large B-cell lymphomas. Nat Commun 2015;6:6921. [PMID: 25891015 DOI: 10.1038/ncomms7921] [Cited by in Crossref: 64] [Cited by in F6Publishing: 74] [Article Influence: 9.1] [Reference Citation Analysis]
66 Papadopoulos T, Belliere J, Bascands JL, Neau E, Klein J, Schanstra JP. miRNAs in urine: a mirror image of kidney disease? Expert Rev Mol Diagn 2015;15:361-74. [PMID: 25660955 DOI: 10.1586/14737159.2015.1009449] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 3.0] [Reference Citation Analysis]
67 Bouamar H, Jiang D, Wang L, Lin AP, Ortega M, Aguiar RC. MicroRNA 155 control of p53 activity is context dependent and mediated by Aicda and Socs1. Mol Cell Biol 2015;35:1329-40. [PMID: 25645925 DOI: 10.1128/MCB.01446-14] [Cited by in Crossref: 26] [Cited by in F6Publishing: 29] [Article Influence: 3.7] [Reference Citation Analysis]
68 Zhang C, Shu L, Kong AN. MicroRNAs: New players in cancer prevention targeting Nrf2, oxidative stress and inflammatory pathways. Curr Pharmacol Rep 2015;1:21-30. [PMID: 26618104 DOI: 10.1007/s40495-014-0013-7] [Cited by in Crossref: 22] [Cited by in F6Publishing: 26] [Article Influence: 3.1] [Reference Citation Analysis]
69 Dai X, Tan C. Combination of microRNA therapeutics with small-molecule anticancer drugs: mechanism of action and co-delivery nanocarriers. Adv Drug Deliv Rev 2015;81:184-97. [PMID: 25281917 DOI: 10.1016/j.addr.2014.09.010] [Cited by in Crossref: 99] [Cited by in F6Publishing: 98] [Article Influence: 14.1] [Reference Citation Analysis]
70 Musilova K, Mraz M. MicroRNAs in B-cell lymphomas: how a complex biology gets more complex. Leukemia 2015;29:1004-17. [PMID: 25541152 DOI: 10.1038/leu.2014.351] [Cited by in Crossref: 152] [Cited by in F6Publishing: 156] [Article Influence: 19.0] [Reference Citation Analysis]
71 Chi JQ, Teng M, Yu ZH, Xu H, Su JW, Zhao P, Xing GX, Liang HD, Deng RG, Qu LH, Zhang GP, Luo J. Marek's disease virus-encoded analog of microRNA-155 activates the oncogene c-Myc by targeting LTBP1 and suppressing the TGF-β signaling pathway. Virology 2015;476:72-84. [PMID: 25528440 DOI: 10.1016/j.virol.2014.11.027] [Cited by in Crossref: 34] [Cited by in F6Publishing: 35] [Article Influence: 4.3] [Reference Citation Analysis]
72 Teng M, Yu ZH, Sun AJ, Min YJ, Chi JQ, Zhao P, Su JW, Cui ZZ, Zhang GP, Luo J. The significance of the individual Meq-clustered miRNAs of Marek's disease virus in oncogenesis. J Gen Virol 2015;96:637-49. [PMID: 25502647 DOI: 10.1099/jgv.0.000013] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 2.0] [Reference Citation Analysis]
73 Ji W, Zhang X, Sun X, Wang X, Chang B, Zhang M. miRNA-155 modulates the malignant biological characteristics of NK/T-cell lymphoma cells by targeting FOXO3a gene. J Huazhong Univ Sci Technol [Med Sci ] 2014;34:882-8. [DOI: 10.1007/s11596-014-1368-z] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 1.5] [Reference Citation Analysis]
74 Butovsky O, Jedrychowski MP, Cialic R, Krasemann S, Murugaiyan G, Fanek Z, Greco DJ, Wu PM, Doykan CE, Kiner O, Lawson RJ, Frosch MP, Pochet N, Fatimy RE, Krichevsky AM, Gygi SP, Lassmann H, Berry J, Cudkowicz ME, Weiner HL. Targeting miR-155 restores abnormal microglia and attenuates disease in SOD1 mice. Ann Neurol 2015;77:75-99. [PMID: 25381879 DOI: 10.1002/ana.24304] [Cited by in Crossref: 184] [Cited by in F6Publishing: 217] [Article Influence: 23.0] [Reference Citation Analysis]
75 Ortega M, Bhatnagar H, Lin AP, Wang L, Aster JC, Sill H, Aguiar RC. A microRNA-mediated regulatory loop modulates NOTCH and MYC oncogenic signals in B- and T-cell malignancies. Leukemia 2015;29:968-76. [PMID: 25311243 DOI: 10.1038/leu.2014.302] [Cited by in Crossref: 36] [Cited by in F6Publishing: 43] [Article Influence: 4.5] [Reference Citation Analysis]
76 Curado F, Spuul P, Egaña I, Rottiers P, Daubon T, Veillat V, Duhamel P, Leclercq A, Gontier E, Génot E. ALK5 and ALK1 play antagonistic roles in transforming growth factor β-induced podosome formation in aortic endothelial cells. Mol Cell Biol 2014;34:4389-403. [PMID: 25266657 DOI: 10.1128/MCB.01026-14] [Cited by in Crossref: 20] [Cited by in F6Publishing: 24] [Article Influence: 2.5] [Reference Citation Analysis]
77 De Tullio G, De Fazio V, Sgherza N, Minoia C, Serratì S, Merchionne F, Loseto G, Iacobazzi A, Rana A, Petrillo P, Silvestris N, Iacopino P, Guarini A. Challenges and opportunities of microRNAs in lymphomas. Molecules 2014;19:14723-81. [PMID: 25232701 DOI: 10.3390/molecules190914723] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 2.6] [Reference Citation Analysis]
78 Feng M, Luo X, Gu C, Fei J. Seed targeting with tiny anti-miR-155 inhibits malignant progression of multiple myeloma cells. J Drug Target 2015;23:59-66. [PMID: 25185784 DOI: 10.3109/1061186X.2014.951653] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 1.3] [Reference Citation Analysis]
79 Huang Y, Liu Y, Li L, Su B, Yang L, Fan W, Yin Q, Chen L, Cui T, Zhang J, Lu Y, Cheng J, Fu P, Liu F. Involvement of inflammation-related miR-155 and miR-146a in diabetic nephropathy: implications for glomerular endothelial injury. BMC Nephrol 2014;15:142. [PMID: 25182190 DOI: 10.1186/1471-2369-15-142] [Cited by in Crossref: 68] [Cited by in F6Publishing: 77] [Article Influence: 8.5] [Reference Citation Analysis]
80 Ren YJ, Zhang Y. An update on RNA interference-mediated gene silencing in cancer therapy. Expert Opin Biol Ther. 2014;14:1581-1592. [PMID: 25010067 DOI: 10.1517/14712598.2014.935334] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 1.4] [Reference Citation Analysis]
81 Chen J, Liu Z, Zhong G, Qian L, Li Z, Qiao Z, Chen B, Wang H. Hypertrophy of ligamentum flavum in lumbar spine stenosis is associated with increased miR-155 level. Dis Markers 2014;2014:786543. [PMID: 24963214 DOI: 10.1155/2014/786543] [Cited by in Crossref: 21] [Cited by in F6Publishing: 27] [Article Influence: 2.6] [Reference Citation Analysis]
82 Xiong Q, Yang Y, Wang H, Li J, Wang S, Li Y, Yang Y, Cai K, Ruan X, Yan J, Hu S, Fang X. Characterization of miRNomes in acute and chronic myeloid leukemia cell lines. Genomics Proteomics Bioinformatics 2014;12:79-91. [PMID: 24755403 DOI: 10.1016/j.gpb.2014.02.001] [Cited by in Crossref: 15] [Cited by in F6Publishing: 18] [Article Influence: 1.9] [Reference Citation Analysis]
83 Chen Z, Ma T, Huang C, Hu T, Li J. The pivotal role of microRNA-155 in the control of cancer. J Cell Physiol 2014;229:545-50. [PMID: 24122356 DOI: 10.1002/jcp.24492] [Cited by in Crossref: 61] [Cited by in F6Publishing: 67] [Article Influence: 7.6] [Reference Citation Analysis]
84 Yao Y, Nair V. Role of virus-encoded microRNAs in Avian viral diseases. Viruses 2014;6:1379-94. [PMID: 24662606 DOI: 10.3390/v6031379] [Cited by in Crossref: 37] [Cited by in F6Publishing: 38] [Article Influence: 4.6] [Reference Citation Analysis]
85 Neumeister P, Sill H. Novel face of microRNA-155. Blood 2014;123:5-7. [PMID: 24385494 DOI: 10.1182/blood-2013-11-534107] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
86 Limpers A, van Royen-Kerkhof A, van Roon JA, Radstake TR, Broen JC. Overlapping gene expression profiles indicative of antigen processing and the interferon pathway characterize inflammatory fibrotic skin diseases. Expert Rev Clin Immunol 2014;10:231-41. [PMID: 24382112 DOI: 10.1586/1744666X.2014.872561] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
87 Cubillos-Ruiz JR, Rutkowski MR, Tchou J, Conejo-Garcia JR. Reprogramming immune responses via microRNA modulation. Microrna Diagn Ther 2013;1:2013-0001. [PMID: 25285232 DOI: 10.2478/micrnat-2013-0001] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
88 Barutta F, Tricarico M, Corbelli A, Annaratone L, Pinach S, Grimaldi S, Bruno G, Cimino D, Taverna D, Deregibus MC. Urinary exosomal microRNAs in incipient diabetic nephropathy. PLoS One. 2013;8:e73798. [PMID: 24223694 DOI: 10.1371/journal.pone.0073798] [Cited by in Crossref: 175] [Cited by in F6Publishing: 193] [Article Influence: 19.4] [Reference Citation Analysis]
89 Yu ZH, Teng M, Sun AJ, Yu LL, Hu B, Qu LH, Ding K, Cheng XC, Liu JX, Cui ZZ, Zhang GP, Luo J. Virus-encoded miR-155 ortholog is an important potential regulator but not essential for the development of lymphomas induced by very virulent Marek's disease virus. Virology 2014;448:55-64. [PMID: 24314636 DOI: 10.1016/j.virol.2013.09.017] [Cited by in Crossref: 33] [Cited by in F6Publishing: 31] [Article Influence: 3.7] [Reference Citation Analysis]
90 Jiang D, Aguiar RC. MicroRNA-155 controls RB phosphorylation in normal and malignant B lymphocytes via the noncanonical TGF-β1/SMAD5 signaling module. Blood 2014;123:86-93. [PMID: 24136167 DOI: 10.1182/blood-2013-07-515254] [Cited by in Crossref: 27] [Cited by in F6Publishing: 32] [Article Influence: 3.0] [Reference Citation Analysis]
91 de Yébenes VG, Bartolomé-Izquierdo N, Ramiro AR. Regulation of B-cell development and function by microRNAs. Immunol Rev. 2013;253:25-39. [PMID: 23550636 DOI: 10.1111/imr.12046] [Cited by in Crossref: 63] [Cited by in F6Publishing: 61] [Article Influence: 7.0] [Reference Citation Analysis]
92 Jardin F, Figeac M. MicroRNAs in lymphoma, from diagnosis to targeted therapy. Current Opinion in Oncology 2013;25:480-6. [DOI: 10.1097/cco.0b013e328363def2] [Cited by in Crossref: 28] [Cited by in F6Publishing: 28] [Article Influence: 3.1] [Reference Citation Analysis]
93 Plank M, Maltby S, Mattes J, Foster PS. Targeting translational control as a novel way to treat inflammatory disease: the emerging role of MicroRNAs. Clin Exp Allergy 2013;43:981-99. [DOI: 10.1111/cea.12135] [Cited by in Crossref: 37] [Cited by in F6Publishing: 17] [Article Influence: 4.1] [Reference Citation Analysis]
94 Clozel T, Yang S, Elstrom RL, Tam W, Martin P, Kormaksson M, Banerjee S, Vasanthakumar A, Culjkovic B, Scott DW, Wyman S, Leser M, Shaknovich R, Chadburn A, Tabbo F, Godley LA, Gascoyne RD, Borden KL, Inghirami G, Leonard JP, Melnick A, Cerchietti L. Mechanism-based epigenetic chemosensitization therapy of diffuse large B-cell lymphoma. Cancer Discov 2013;3:1002-19. [PMID: 23955273 DOI: 10.1158/2159-8290.CD-13-0117] [Cited by in Crossref: 128] [Cited by in F6Publishing: 112] [Article Influence: 14.2] [Reference Citation Analysis]
95 Bouamar H, Abbas S, Lin AP, Wang L, Jiang D, Holder KN, Kinney MC, Hunicke-Smith S, Aguiar RC. A capture-sequencing strategy identifies IRF8, EBF1, and APRIL as novel IGH fusion partners in B-cell lymphoma. Blood 2013;122:726-33. [PMID: 23775715 DOI: 10.1182/blood-2013-04-495804] [Cited by in Crossref: 30] [Cited by in F6Publishing: 34] [Article Influence: 3.3] [Reference Citation Analysis]
96 Toledo RA, Qin Y, Srikantan S, Morales NP, Li Q, Deng Y, Kim SW, Pereira MA, Toledo SP, Su X, Aguiar RC, Dahia PL. In vivo and in vitro oncogenic effects of HIF2A mutations in pheochromocytomas and paragangliomas. Endocr Relat Cancer 2013;20:349-59. [PMID: 23533246 DOI: 10.1530/ERC-13-0101] [Cited by in Crossref: 83] [Cited by in F6Publishing: 90] [Article Influence: 9.2] [Reference Citation Analysis]
97 Lawrie CH. MicroRNAs in hematological malignancies. Blood Rev. 2013;27:143-154. [PMID: 23623930 DOI: 10.1016/j.blre.2013.04.002] [Cited by in Crossref: 39] [Cited by in F6Publishing: 39] [Article Influence: 4.3] [Reference Citation Analysis]
98 Tili E, Michaille J, Croce CM. MicroRNAs play a central role in molecular dysfunctions linking inflammation with cancer. Immunol Rev 2013;253:167-84. [DOI: 10.1111/imr.12050] [Cited by in Crossref: 151] [Cited by in F6Publishing: 160] [Article Influence: 16.8] [Reference Citation Analysis]
99 Larsen MT, Hother C, Häger M, Pedersen CC, Theilgaard-Mönch K, Borregaard N, Cowland JB. MicroRNA profiling in human neutrophils during bone marrow granulopoiesis and in vivo exudation. PLoS One 2013;8:e58454. [PMID: 23554893 DOI: 10.1371/journal.pone.0058454] [Cited by in Crossref: 28] [Cited by in F6Publishing: 26] [Article Influence: 3.1] [Reference Citation Analysis]
100 Zhang X, Zhang Z, Zheng B, He Z, Winberg G, Ernberg I. An update on viral association of human cancers. Arch Virol 2013;158:1433-43. [PMID: 23417394 DOI: 10.1007/s00705-013-1623-9] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 1.3] [Reference Citation Analysis]
101 Zhou H, Wang K, Hu Z, Wen J. TGF-β1 alters microRNA profile in human gastric cancer cells. Chin J Cancer Res. 2013;25:102-111. [PMID: 23372348 DOI: 10.3978/j.issn.1000-9604.2013.01.09] [Cited by in F6Publishing: 13] [Reference Citation Analysis]
102 Sionov RV. MicroRNAs and Glucocorticoid-Induced Apoptosis in Lymphoid Malignancies. ISRN Hematol. 2013;2013:348212. [PMID: 23431463 DOI: 10.1155/2013/348212] [Cited by in Crossref: 18] [Cited by in F6Publishing: 21] [Article Influence: 2.0] [Reference Citation Analysis]
103 Lawrie CH. MicroRNAs and lymphomagenesis: a functional review. Br J Haematol 2013;160:571-81. [PMID: 23205669 DOI: 10.1111/bjh.12157] [Cited by in Crossref: 51] [Cited by in F6Publishing: 51] [Article Influence: 5.1] [Reference Citation Analysis]
104 Li C, Hashimi SM, Good DA, Cao S, Duan W, Plummer PN, Mellick AS, Wei MQ. Apoptosis and microRNA aberrations in cancer. Clin Exp Pharmacol Physiol 2012;39:739-46. [PMID: 22409455 DOI: 10.1111/j.1440-1681.2012.05700.x] [Cited by in Crossref: 41] [Cited by in F6Publishing: 37] [Article Influence: 4.1] [Reference Citation Analysis]
105 Basso K, Schneider C, Shen Q, Holmes AB, Setty M, Leslie C, Dalla-Favera R. BCL6 positively regulates AID and germinal center gene expression via repression of miR-155. J Exp Med 2012;209:2455-65. [PMID: 23166356 DOI: 10.1084/jem.20121387] [Cited by in Crossref: 85] [Cited by in F6Publishing: 80] [Article Influence: 8.5] [Reference Citation Analysis]
106 Loeb GB, Khan AA, Canner D, Hiatt JB, Shendure J, Darnell RB, Leslie CS, Rudensky AY. Transcriptome-wide miR-155 binding map reveals widespread noncanonical microRNA targeting. Mol Cell. 2012;48:760-770. [PMID: 23142080 DOI: 10.1016/j.molcel.2012.10.002] [Cited by in Crossref: 240] [Cited by in F6Publishing: 236] [Article Influence: 24.0] [Reference Citation Analysis]
107 Yao R, Ma YL, Liang W, Li HH, Ma ZJ, Yu X, Liao YH. MicroRNA-155 modulates Treg and Th17 cells differentiation and Th17 cell function by targeting SOCS1. PLoS One. 2012;7:e46082. [PMID: 23091595 DOI: 10.1371/journal.pone.0046082] [Cited by in Crossref: 181] [Cited by in F6Publishing: 198] [Article Influence: 18.1] [Reference Citation Analysis]
108 Mo MH, Chen L, Fu Y, Wang W, Fu SW. Cell-free Circulating miRNA Biomarkers in Cancer. J Cancer. 2012;3:432-448. [PMID: 23074383 DOI: 10.7150/jca.4919] [Cited by in Crossref: 93] [Cited by in F6Publishing: 98] [Article Influence: 9.3] [Reference Citation Analysis]
109 Li L, Shi JY, Zhu GQ, Shi B. MiR-17-92 cluster regulates cell proliferation and collagen synthesis by targeting TGFB pathway in mouse palatal mesenchymal cells. J Cell Biochem 2012;113:1235-44. [PMID: 22095742 DOI: 10.1002/jcb.23457] [Cited by in Crossref: 74] [Cited by in F6Publishing: 79] [Article Influence: 7.4] [Reference Citation Analysis]
110 Huse K, Bakkebø M, Wälchli S, Oksvold MP, Hilden VI, Forfang L, Bredahl ML, Liestøl K, Alizadeh AA, Smeland EB, Myklebust JH. Role of Smad proteins in resistance to BMP-induced growth inhibition in B-cell lymphoma. PLoS One 2012;7:e46117. [PMID: 23049692 DOI: 10.1371/journal.pone.0046117] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 1.5] [Reference Citation Analysis]
111 Ramalingam D, Kieffer-Kwon P, Ziegelbauer JM. Emerging themes from EBV and KSHV microRNA targets. Viruses 2012;4:1687-710. [PMID: 23170179 DOI: 10.3390/v4091687] [Cited by in Crossref: 45] [Cited by in F6Publishing: 44] [Article Influence: 4.5] [Reference Citation Analysis]
112 Kubiczkova L, Sedlarikova L, Hajek R, Sevcikova S. TGF-β - an excellent servant but a bad master. J Transl Med 2012;10:183. [PMID: 22943793 DOI: 10.1186/1479-5876-10-183] [Cited by in Crossref: 207] [Cited by in F6Publishing: 241] [Article Influence: 20.7] [Reference Citation Analysis]
113 Lei X, Zhu Y, Jones T, Bai Z, Huang Y, Gao SJ. A Kaposi's sarcoma-associated herpesvirus microRNA and its variants target the transforming growth factor β pathway to promote cell survival. J Virol 2012;86:11698-711. [PMID: 22915806 DOI: 10.1128/JVI.06855-11] [Cited by in Crossref: 60] [Cited by in F6Publishing: 56] [Article Influence: 6.0] [Reference Citation Analysis]
114 Butovsky O, Siddiqui S, Gabriely G, Lanser AJ, Dake B, Murugaiyan G, Doykan CE, Wu PM, Gali RR, Iyer LK, Lawson R, Berry J, Krichevsky AM, Cudkowicz ME, Weiner HL. Modulating inflammatory monocytes with a unique microRNA gene signature ameliorates murine ALS. J Clin Invest 2012;122:3063-87. [PMID: 22863620 DOI: 10.1172/JCI62636] [Cited by in Crossref: 278] [Cited by in F6Publishing: 308] [Article Influence: 27.8] [Reference Citation Analysis]
115 Bhattacharya A, Schmitz U, Wolkenhauer O, Schönherr M, Raatz Y, Kunz M. Regulation of cell cycle checkpoint kinase WEE1 by miR-195 in malignant melanoma. Oncogene 2013;32:3175-83. [PMID: 22847610 DOI: 10.1038/onc.2012.324] [Cited by in Crossref: 61] [Cited by in F6Publishing: 66] [Article Influence: 6.1] [Reference Citation Analysis]
116 Das LM, Torres-Castillo MD, Gill T, Levine AD. TGF-β conditions intestinal T cells to express increased levels of miR-155, associated with down-regulation of IL-2 and itk mRNA. Mucosal Immunol 2013;6:167-76. [PMID: 22785227 DOI: 10.1038/mi.2012.60] [Cited by in Crossref: 23] [Cited by in F6Publishing: 27] [Article Influence: 2.3] [Reference Citation Analysis]
117 Hinck AP. Structural studies of the TGF-βs and their receptors - insights into evolution of the TGF-β superfamily. FEBS Lett 2012;586:1860-70. [PMID: 22651914 DOI: 10.1016/j.febslet.2012.05.028] [Cited by in Crossref: 135] [Cited by in F6Publishing: 135] [Article Influence: 13.5] [Reference Citation Analysis]
118 Wu T, Xie M, Wang X, Jiang X, Li J, Huang H. miR-155 modulates TNF-α-inhibited osteogenic differentiation by targeting SOCS1 expression. Bone 2012;51:498-505. [PMID: 22634176 DOI: 10.1016/j.bone.2012.05.013] [Cited by in Crossref: 56] [Cited by in F6Publishing: 59] [Article Influence: 5.6] [Reference Citation Analysis]
119 Butz H, Rácz K, Hunyady L, Patócs A. Crosstalk between TGF-β signaling and the microRNA machinery. Trends Pharmacol Sci 2012;33:382-93. [PMID: 22613783 DOI: 10.1016/j.tips.2012.04.003] [Cited by in Crossref: 147] [Cited by in F6Publishing: 149] [Article Influence: 14.7] [Reference Citation Analysis]
120 Gottwein E. Kaposi's Sarcoma-Associated Herpesvirus microRNAs. Front Microbiol 2012;3:165. [PMID: 22563327 DOI: 10.3389/fmicb.2012.00165] [Cited by in Crossref: 48] [Cited by in F6Publishing: 46] [Article Influence: 4.8] [Reference Citation Analysis]
121 Kim SW, Ramasamy K, Bouamar H, Lin AP, Jiang D, Aguiar RC. MicroRNAs miR-125a and miR-125b constitutively activate the NF-κB pathway by targeting the tumor necrosis factor alpha-induced protein 3 (TNFAIP3, A20). Proc Natl Acad Sci U S A 2012;109:7865-70. [PMID: 22550173 DOI: 10.1073/pnas.1200081109] [Cited by in Crossref: 224] [Cited by in F6Publishing: 225] [Article Influence: 22.4] [Reference Citation Analysis]
122 Sun Y, Cai J, Ma F, Lü P, Huang H, Zhou J. miR-155 mediates suppressive effect of progesterone on TLR3, TLR4-triggered immune response. Immunol Lett 2012;146:25-30. [PMID: 22546503 DOI: 10.1016/j.imlet.2012.04.007] [Cited by in Crossref: 41] [Cited by in F6Publishing: 46] [Article Influence: 4.1] [Reference Citation Analysis]
123 Koch M, Mollenkopf HJ, Klemm U, Meyer TF. Induction of microRNA-155 is TLR- and type IV secretion system-dependent in macrophages and inhibits DNA-damage induced apoptosis. Proc Natl Acad Sci USA. 2012;109:E1153-E1162. [PMID: 22509021 DOI: 10.1073/pnas.1116125109] [Cited by in Crossref: 81] [Cited by in F6Publishing: 78] [Article Influence: 8.1] [Reference Citation Analysis]
124 Li S, Chen T, Zhong Z, Wang Y, Li Y, Zhao X. microRNA-155 silencing inhibits proliferation and migration and induces apoptosis by upregulating BACH1 in renal cancer cells. Mol Med Rep 2012;5:949-54. [PMID: 22307849 DOI: 10.3892/mmr.2012.779] [Cited by in Crossref: 49] [Cited by in F6Publishing: 51] [Article Influence: 4.9] [Reference Citation Analysis]
125 Blahna MT, Hata A. Smad-mediated regulation of microRNA biosynthesis. FEBS Lett 2012;586:1906-12. [PMID: 22306316 DOI: 10.1016/j.febslet.2012.01.041] [Cited by in Crossref: 88] [Cited by in F6Publishing: 84] [Article Influence: 8.8] [Reference Citation Analysis]
126 Turcatel G, Rubin N, El-Hashash A, Warburton D. MIR-99a and MIR-99b modulate TGF-β induced epithelial to mesenchymal plasticity in normal murine mammary gland cells. PLoS One 2012;7:e31032. [PMID: 22299047 DOI: 10.1371/journal.pone.0031032] [Cited by in Crossref: 83] [Cited by in F6Publishing: 83] [Article Influence: 8.3] [Reference Citation Analysis]
127 Wilmott JS, Zhang XD, Hersey P, Scolyer RA. The emerging important role of microRNAs in the pathogenesis, diagnosis and treatment of human cancers. Pathology 2011;43:657-71. [PMID: 21876471 DOI: 10.1097/PAT.0b013e32834a7358] [Cited by in Crossref: 31] [Cited by in F6Publishing: 32] [Article Influence: 3.1] [Reference Citation Analysis]
128 Wang T, Zhang L, Shi C, Sun H, Wang J, Li R, Zou Z, Ran X, Su Y. TGF-β-induced miR-21 negatively regulates the antiproliferative activity but has no effect on EMT of TGF-β in HaCaT cells. Int J Biochem Cell Biol 2012;44:366-76. [PMID: 22119803 DOI: 10.1016/j.biocel.2011.11.012] [Cited by in Crossref: 43] [Cited by in F6Publishing: 46] [Article Influence: 3.9] [Reference Citation Analysis]
129 Dagan LN, Jiang X, Bhatt S, Cubedo E, Rajewsky K, Lossos IS. miR-155 regulates HGAL expression and increases lymphoma cell motility. Blood 2012;119:513-20. [PMID: 22096245 DOI: 10.1182/blood-2011-08-370536] [Cited by in Crossref: 51] [Cited by in F6Publishing: 45] [Article Influence: 4.6] [Reference Citation Analysis]
130 Iyevleva AG, Kuligina ESh, Mitiushkina NV, Togo AV, Miki Y, Imyanitov EN. High level of miR-21, miR-10b, and miR-31 expression in bilateral vs. unilateral breast carcinomas. Breast Cancer Res Treat 2012;131:1049-59. [PMID: 22057972 DOI: 10.1007/s10549-011-1845-z] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 1.8] [Reference Citation Analysis]
131 Liu Y, Sun R, Lin X, Liang D, Deng Q, Lan K. Kaposi's sarcoma-associated herpesvirus-encoded microRNA miR-K12-11 attenuates transforming growth factor beta signaling through suppression of SMAD5. J Virol 2012;86:1372-81. [PMID: 22013049 DOI: 10.1128/JVI.06245-11] [Cited by in Crossref: 67] [Cited by in F6Publishing: 61] [Article Influence: 6.1] [Reference Citation Analysis]
132 Boss IW, Nadeau PE, Abbott JR, Yang Y, Mergia A, Renne R. A Kaposi's sarcoma-associated herpesvirus-encoded ortholog of microRNA miR-155 induces human splenic B-cell expansion in NOD/LtSz-scid IL2Rγnull mice. J Virol 2011;85:9877-86. [PMID: 21813606 DOI: 10.1128/JVI.05558-11] [Cited by in Crossref: 87] [Cited by in F6Publishing: 83] [Article Influence: 7.9] [Reference Citation Analysis]
133 Bruning U, Cerone L, Neufeld Z, Fitzpatrick SF, Cheong A, Scholz CC, Simpson DA, Leonard MO, Tambuwala MM, Cummins EP. MicroRNA-155 promotes resolution of hypoxia-inducible factor 1alpha activity during prolonged hypoxia. Mol Cell Biol. 2011;31:4087-4096. [PMID: 21807897 DOI: 10.1128/mcb.01276-10] [Cited by in Crossref: 186] [Cited by in F6Publishing: 188] [Article Influence: 16.9] [Reference Citation Analysis]
134 Zuniga JE, Ilangovan U, Mahlawat P, Hinck CS, Huang T, Groppe JC, McEwen DG, Hinck AP. The TβR-I pre-helix extension is structurally ordered in the unbound form and its flanking prolines are essential for binding. J Mol Biol 2011;412:601-18. [PMID: 21821041 DOI: 10.1016/j.jmb.2011.07.046] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 1.2] [Reference Citation Analysis]
135 Kim SW, Rai D, Aguiar RC. Gene set enrichment analysis unveils the mechanism for the phosphodiesterase 4B control of glucocorticoid response in B-cell lymphoma. Clin Cancer Res 2011;17:6723-32. [PMID: 21742807 DOI: 10.1158/1078-0432.CCR-11-0770] [Cited by in Crossref: 26] [Cited by in F6Publishing: 28] [Article Influence: 2.4] [Reference Citation Analysis]
136 Wang L, Toomey NL, Diaz LA, Walker G, Ramos JC, Barber GN, Ning S. Oncogenic IRFs provide a survival advantage for Epstein-Barr virus- or human T-cell leukemia virus type 1-transformed cells through induction of BIC expression. J Virol 2011;85:8328-37. [PMID: 21680528 DOI: 10.1128/JVI.00570-11] [Cited by in Crossref: 36] [Cited by in F6Publishing: 33] [Article Influence: 3.3] [Reference Citation Analysis]
137 Du ZM, Hu LF, Wang HY, Yan LX, Zeng YX, Shao JY, Ernberg I. Upregulation of MiR-155 in nasopharyngeal carcinoma is partly driven by LMP1 and LMP2A and downregulates a negative prognostic marker JMJD1A. PLoS One 2011;6:e19137. [PMID: 21541331 DOI: 10.1371/journal.pone.0019137] [Cited by in Crossref: 70] [Cited by in F6Publishing: 65] [Article Influence: 6.4] [Reference Citation Analysis]
138 Sandhu SK, Croce CM, Garzon R. Micro-RNA Expression and Function in Lymphomas. Adv Hematol 2011;2011:347137. [PMID: 21461378 DOI: 10.1155/2011/347137] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 1.9] [Reference Citation Analysis]
139 Dogar AM, Towbin H, Hall J. Suppression of latent transforming growth factor (TGF)-beta1 restores growth inhibitory TGF-beta signaling through microRNAs. J Biol Chem 2011;286:16447-58. [PMID: 21402698 DOI: 10.1074/jbc.M110.208652] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 2.2] [Reference Citation Analysis]
140 Zhao Y, Xu H, Yao Y, Smith LP, Kgosana L, Green J, Petherbridge L, Baigent SJ, Nair V. Critical role of the virus-encoded microRNA-155 ortholog in the induction of Marek's disease lymphomas. PLoS Pathog 2011;7:e1001305. [PMID: 21383974 DOI: 10.1371/journal.ppat.1001305] [Cited by in Crossref: 136] [Cited by in F6Publishing: 130] [Article Influence: 12.4] [Reference Citation Analysis]
141 Auer RL. The coming of age of microRNA for B cell lymphomas: microRNA for B cell lymphomas. Histopathology 2011;58:39-48. [DOI: 10.1111/j.1365-2559.2010.03698.x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
142 Imig J, Motsch N, Zhu JY, Barth S, Okoniewski M, Reineke T, Tinguely M, Faggioni A, Trivedi P, Meister G, Renner C, Grässer FA. microRNA profiling in Epstein-Barr virus-associated B-cell lymphoma. Nucleic Acids Res 2011;39:1880-93. [PMID: 21062812 DOI: 10.1093/nar/gkq1043] [Cited by in Crossref: 106] [Cited by in F6Publishing: 105] [Article Influence: 8.8] [Reference Citation Analysis]
143 Louafi F, Martinez-Nunez RT, Sanchez-Elsner T. MicroRNA-155 targets SMAD2 and modulates the response of macrophages to transforming growth factor-{beta}. J Biol Chem 2010;285:41328-36. [PMID: 21036908 DOI: 10.1074/jbc.M110.146852] [Cited by in Crossref: 141] [Cited by in F6Publishing: 141] [Article Influence: 11.8] [Reference Citation Analysis]
144 Dews M, Fox JL, Hultine S, Sundaram P, Wang W, Liu YY, Furth E, Enders GH, El-Deiry W, Schelter JM. The myc-miR-17~92 axis blunts TGF{beta} signaling and production of multiple TGF{beta}-dependent antiangiogenic factors. Cancer Res. 2010;70:8233-8246. [PMID: 20940405 DOI: 10.1158/0008-5472.can-10-2412] [Cited by in Crossref: 188] [Cited by in F6Publishing: 186] [Article Influence: 15.7] [Reference Citation Analysis]
145 Wang P, Hou J, Lin L, Wang C, Liu X, Li D, Ma F, Wang Z, Cao X. Inducible microRNA-155 feedback promotes type I IFN signaling in antiviral innate immunity by targeting suppressor of cytokine signaling 1. J Immunol. 2010;185:6226-6233. [PMID: 20937844 DOI: 10.4049/jimmunol.1000491] [Cited by in Crossref: 295] [Cited by in F6Publishing: 307] [Article Influence: 24.6] [Reference Citation Analysis]
146 O’Connell RM, Kahn D, Gibson WS, Round JL, Scholz RL, Chaudhuri AA, Kahn ME, Rao DS, Baltimore D. MicroRNA-155 promotes autoimmune inflammation by enhancing inflammatory T cell development. Immunity. 2010;33:607-619. [PMID: 20888269 DOI: 10.1016/j.immuni.2010.09.009] [Cited by in Crossref: 614] [Cited by in F6Publishing: 633] [Article Influence: 51.2] [Reference Citation Analysis]
147 Linnstaedt SD, Gottwein E, Skalsky RL, Luftig MA, Cullen BR. Virally induced cellular microRNA miR-155 plays a key role in B-cell immortalization by Epstein-Barr virus. J Virol 2010;84:11670-8. [PMID: 20844043 DOI: 10.1128/JVI.01248-10] [Cited by in Crossref: 135] [Cited by in F6Publishing: 135] [Article Influence: 11.3] [Reference Citation Analysis]
148 Yin Q, Wang X, Fewell C, Cameron J, Zhu H, Baddoo M, Lin Z, Flemington EK. MicroRNA miR-155 inhibits bone morphogenetic protein (BMP) signaling and BMP-mediated Epstein-Barr virus reactivation. J Virol 2010;84:6318-27. [PMID: 20427544 DOI: 10.1128/JVI.00635-10] [Cited by in Crossref: 67] [Cited by in F6Publishing: 67] [Article Influence: 5.6] [Reference Citation Analysis]